June 11, 2021 News by Patricia Inacio, PhD Stem Cell Transplant Trial Enrolls First Patient in Minnesota A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of multiple sclerosis (MS) has enrolled a patient in Minnesota. The patient was enrolled at the University of Minnesota Medical School, one of two trial sitesĀ in the state. An additional 18…
November 13, 2020 News by Joana Carvalho, PhD Bone Marrow Transplant Most Useful for Younger Patients, MS Society Experts Suggest A bone marrow transplant may be particularly useful for those with relapsing forms of multiple sclerosis (MS) who, despite treatment with high-efficacy disease-modifying therapies (DMTs), continue to experience relapses or show signs of new lesions, experts say. According to new recommendations from the National Multiple Sclerosis Society,…
November 10, 2020 News by Marta Figueiredo, PhD Stem Cell Transplant More Effective Than Lemtrada in Treating RRMS, Study Suggests An autologous hematopoietic stem cell transplantĀ (AHSCT) is more effective than LemtradaĀ (alemtuzumab) at achieving no evidence of disease activity and preventing relapses in people with relapsing-remitting multiple sclerosisĀ (RRMS), a real-life study in Sweden reported. Adverse events (side effects) were more frequent with AHSCT over the first three…
October 30, 2020 Columns by Ed Tobias aHSCT Gets a Boost in US With NMSS Recommendations Is the United States a step closer to approving a form of stem cell transplantation as a treatment for multiple sclerosis? I believe it may be. That’s because the National Multiple Sclerosis Society (NMSS) has slightly changed its view of autologous hematopoietic stem cell transplantation, or aHSCT. aHSCT involves…
January 17, 2020 Columns by Ed Tobias Stem Cells Versus DMTs: MS Treatments Go Head to Head People with multiple sclerosis have been waiting for this: A full-scale clinical trial testing the effectiveness of stem cell transplantation as an MS treatment. The trial is being conducted by the U.S. National Institutes of Health, and it’s enrolling people with MSĀ at several centers in the United States and…
January 9, 2020 News by Vanessa Pataia New Trial Compares Stem Cell Treatment to Available Therapies for Severe Relapsing MS A new clinical trial is comparing the best available therapies to an experimental stem cell therapy to treat severe forms of relapsing multiple sclerosis (MS). At the moment, more than a dozen therapies have been approved by the U.S. Food and Drug Administration for the treatment of relapsing forms…